Literature DB >> 20467887

The mucosal immune response to plant-derived vaccines.

Kathleen Laura Hefferon1.   

Abstract

Transgenic plants present enormous potential as one of the most cost-effective and safe systems for large-scale production of proteins for industrial, pharmaceutical, veterinary and agricultural uses. Heat-stable plant-derived vaccines that are administered orally could in effect enhance vaccine coverage in children and infants, particularly in developing countries. Here we discuss the current status of plant-derived vaccines and their potential to champion the battle against infectious diseases in the least developed countries.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20467887     DOI: 10.1007/s11095-010-0168-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

Review 1.  Plant biopharming of monoclonal antibodies.

Authors:  Kisung Ko; Hilary Koprowski
Journal:  Virus Res       Date:  2005-04-19       Impact factor: 3.303

2.  Production of human alpha-1-antitrypsin from transgenic rice cell culture in a membrane bioreactor.

Authors:  Karen A McDonald; Lo Ming Hong; David M Trombly; Qing Xie; Alan P Jackman
Journal:  Biotechnol Prog       Date:  2005 May-Jun

Review 3.  Plant-derived vaccines: a look back at the highlights and a view to the challenges on the road ahead.

Authors:  Yasmin Thanavala; Zhong Huang; Hugh S Mason
Journal:  Expert Rev Vaccines       Date:  2006-04       Impact factor: 5.217

4.  Biochemical safety evaluation of transgenic rice seeds expressing T cell epitopes of Japanese cedar pollen allergens.

Authors:  Hidenori Takagi; Sakiko Hirose; Hiroshi Yasuda; Fumio Takaiwa
Journal:  J Agric Food Chem       Date:  2006-12-27       Impact factor: 5.279

5.  Plant pharming of a full-sized, tumour-targeting antibody using different expression strategies.

Authors:  Maria Elena Villani; Bogdan Morgun; Patrizia Brunetti; Carla Marusic; Raffaele Lombardi; Ivan Pisoni; Camilla Bacci; Angiola Desiderio; Eugenio Benvenuto; Marcello Donini
Journal:  Plant Biotechnol J       Date:  2008-09-10       Impact factor: 9.803

Review 6.  Analytical strategies to investigate plant N-glycan profiles in the context of plant-made pharmaceuticals.

Authors:  Muriel Bardor; Gleysin Cabrera; Pauline M Rudd; Raymond A Dwek; José A Cremata; Patrice Lerouge
Journal:  Curr Opin Struct Biol       Date:  2006-09-11       Impact factor: 6.809

7.  Receptor-mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory system.

Authors:  Arati Limaye; Vijay Koya; Mohtashem Samsam; Henry Daniell
Journal:  FASEB J       Date:  2006-04-07       Impact factor: 5.191

Review 8.  Plant-based oral vaccines: results of human trials.

Authors:  C O Tacket
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

9.  A plant-based allergy vaccine suppresses experimental asthma via an IFN-gamma and CD4+CD45RBlow T cell-dependent mechanism.

Authors:  Vanessa Smart; Paul S Foster; Marc E Rothenberg; T J V Higgins; S P Hogan
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

10.  Low-dose exposure and immunogenicity of transgenic maize expressing the Escherichia coli heat-labile toxin B subunit.

Authors:  April J Beyer; Kan Wang; Amber N Umble; Jeffrey D Wolt; Joan E Cunnick
Journal:  Environ Health Perspect       Date:  2006-12-19       Impact factor: 9.031

  10 in total
  4 in total

1.  Effect of diclazuril on intestinal morphology and SIgA expression in chicken infected with Eimeria tenella.

Authors:  Er-jie Tian; Bian-hua Zhou; Xue-ying Wang; Jing Zhao; Wen Deng; Hong-wei Wang
Journal:  Parasitol Res       Date:  2014-08-26       Impact factor: 2.289

2.  Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine.

Authors:  Lissette S Velasquez; Samantha Shira; Alice N Berta; Jacquelyn Kilbourne; Babu M Medi; Ian Tizard; Yawei Ni; Charles J Arntzen; Melissa M Herbst-Kralovetz
Journal:  Vaccine       Date:  2011-06-02       Impact factor: 3.641

Review 3.  Plant-made vaccines in support of the Millennium Development Goals.

Authors:  Claire A Penney; David R Thomas; Sadia S Deen; Amanda M Walmsley
Journal:  Plant Cell Rep       Date:  2011-01-18       Impact factor: 4.570

4.  Oral edible plant vaccine containing hypoallergen of American cockroach major allergen Per a 2 prevents roach-allergic asthma in a murine model.

Authors:  Mey-Fann Lee; Chu-Hui Chiang; Ying-Lan Li; Nancy M Wang; Pei-Pong Song; Shyh-Jye Lin; Yi-Hsing Chen
Journal:  PLoS One       Date:  2018-07-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.